Abstract P2-12-23: A phase 2 trial combining tiragolumab and atezolizumab with neoadjuvant or first line chemotherapy for triple negative breast cancer (SKYLINE)François‐Clément Bidard, Fatima Mechta-Grigoriou, Laurence Champion et al.|Clinical Cancer Research|2025Cited by 0